Literature DB >> 12525903

Alterations of susceptibility of Pseudomonas aeruginosa by overproduction of multidrug efflux systems, MexAB-OprM, MexCD-OprJ, and MexXY/OprM to carbapenems: substrate specificities of the efflux systems.

Kiyomi Okamoto1, Naomasa Gotoh, Takeshi Nishino.   

Abstract

Overproduction of multidrug efflux systems MexAB-OprM, MexCD-OprJ, and MexXY/OprM of Pseudomonas aeruginosa caused reduction of susceptibility of the mutant, which lacked AmpC and all three systems to panipenem, meropenem, S4661 and DU6681a; meropenem, S4661 and DU6681a; and BO2727, panipenem, meropenem, S4661 and DU6681a, respectively, but not reduction of the susceptibility to imipenem and biapenem. Thus, we determined substrate specificities of these efflux systems to carbapenems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12525903     DOI: 10.1007/s10156-002-0193-7

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  15 in total

1.  The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility.

Authors:  Veronica N Kos; Maxime Déraspe; Robert E McLaughlin; James D Whiteaker; Paul H Roy; Richard A Alm; Jacques Corbeil; Humphrey Gardner
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.

Authors:  Diansy Zincke; Deepak Balasubramanian; Lynn L Silver; Kalai Mathee
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

5.  Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.

Authors:  Jane Kriengkauykiat; Edith Porter; Olga Lomovskaya; Annie Wong-Beringer
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa.

Authors:  S A Dunham; C J McPherson; A A Miller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-23       Impact factor: 3.267

7.  A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.

Authors:  Gregory T Robertson; Timothy B Doyle; Qun Du; Leonard Duncan; Khisimuzi E Mdluli; A Simon Lynch
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

Review 8.  Doripenem: a review of its use in the treatment of bacterial infections.

Authors:  Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.

Authors:  Fátima Galán-Sánchez; Germán Bou; Antonio Oliver; Jorge Arca-Suárez; Pablo Fraile-Ribot; Juan Carlos Vázquez-Ucha; Gabriel Cabot; Marta Martínez-Guitián; Emilio Lence; Concepción González-Bello; Alejandro Beceiro; Manuel Rodríguez-Iglesias
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

10.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.